[Skip to content]

Print this page
.

2.11 Antifibrinolytic drugs and haemostatics

Tranexamic acid tablets, injection

Note:

Tranexamic acid is included for the treatment of menorrhagia

Blood Products

Drotrecogin Alfa (activated) for severe sepsis in multiple organ failure has been withdrawn following results from the PROWESS-SHOCK study which failed to show significant reduction in 28-day all-case mortality in patients with septic shock.

For link to BNF section: 2.11 Antifibrinolytic drugs and haemostatics